Skip to content
Reviewed against editorial standards · Updated 2026-02-27

Tirzepatide: Dosage & Administration

Part of the Tirzepatide Complete Guide

Partner

Research Peptides

BioLongevity Labs15% Off
Shop Peptides at BioLongevity Labs

Advertiser link — we may earn a commission at no extra cost to you.

FDA-Approved Dosing Schedule

Tirzepatide (brand names Mounjaro for diabetes, Zepbound for weight management) uses a mandatory dose titration schedule. The 2.5 mg starting dose is a titration-only dose — it is not a therapeutic maintenance dose.

PhaseDoseDurationNotes
Starting2.5 mg weekly4 weeksTitration only — not a maintenance dose
First increase5 mg weekly4+ weeksFirst potential maintenance dose
Second increase7.5 mg weekly4 weeksTitration dose
Third increase10 mg weekly4+ weeksSecond potential maintenance dose
Fourth increase12.5 mg weekly4 weeksTitration dose
Maximum15 mg weeklyMaintenanceHighest FDA-approved dose

Key dosing principles:

  • Dose titration is mandatory. Starting at higher doses causes severe GI side effects. Each increase is 2.5 mg every 4 weeks minimum
  • Maintenance dose flexibility: Not everyone needs the maximum dose. Many patients achieve satisfactory results at 5 mg or 10 mg. Maintenance dose depends on individual response and tolerability
  • For diabetes (Mounjaro): Target dose is 5–15 mg based on glycemic control
  • For weight loss (Zepbound): Target dose is typically 10–15 mg for maximum weight loss

For comparison with semaglutide dosing, see tirzepatide vs semaglutide.

Administration & Injection Technique

Tirzepatide is administered as a once-weekly subcutaneous injection using pre-filled auto-injector pens:

  • Injection sites: Abdomen, thigh, or upper arm — rotate sites weekly to prevent lipodystrophy
  • Timing: Any day of the week, any time of day, with or without meals. Choose a consistent day each week
  • Day change: The injection day can be changed as long as the last dose was at least 3 days (72 hours) prior
  • Pen use: Each pen contains one dose. The pen is single-use and should be discarded after injection. The needle is hidden in auto-injector designs

Missed Dose Protocol

  • If within 4 days (96 hours) of the scheduled dose: administer as soon as possible
  • If more than 4 days late: skip the missed dose and resume on the next scheduled day
  • Resume the regular once-weekly schedule from the new day

Storage & Handling

FormStorageDuration
Unopened pensRefrigerate 2–8°C (36–46°F)Until expiration date
Unopened at room tempUp to 30°C (86°F)Up to 21 days, then discard
Do not freezeDiscard if frozen

Protect from light. Do not use if solution appears cloudy, discolored, or contains particles. For research-grade lyophilized tirzepatide, use the peptide calculator for reconstitution volumes and the storage guide for handling protocols.

FAQ

Frequently Asked Questions

References

  1. [1] Jastreboff AM, et al.. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 2022.
  2. [2] Frias JP, et al.. Tirzepatide versus semaglutide once weekly in type 2 diabetes. New England Journal of Medicine, 2021.

Researching peptides? We did the hard part.

Get our free Peptide Starter Kit — the 5 most researched compounds, simplified into one actionable guide.

No spam · Unsubscribe anytime

Related Reading

AD
Austin Danner

Founder & Editor in Chief

Founder of Peptides Insider. Independent researcher focused on translating peer-reviewed peptide research into practical, evidence-based guides.

Reviewed against Peptides Insider editorial standards · Last reviewed 2026-02-27.